KDM1A and prostate carcinoma: To determine the status of LSD1 in human prostate cancer, LSD1 expression was examined by immunohistochemistry, and the staining intensity was scored using prostate cancer tissue arrays that contain tumors with different Gleason patterns as well as normal prostate tissues.